Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Effects of P-glycoprotein Modulators on Etoposide Elimination and Central Nervous System Distribution

David E. Burgio, Michael P. Gosl and and Patrick J. McNamara
Journal of Pharmacology and Experimental Therapeutics December 1998, 287 (3) 911-917;
David E. Burgio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Gosl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
and Patrick J. McNamara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

In this study, P-glycoprotein modulator effects on pharmacokinetics and central nervous system distribution of the chemotherapeutic agent etoposide were evaluated. The multidrug resistance transporter P-glycoprotein is expressed in normal tissues, and its physiological function is thought to be an excretory and/or protective one. To examine this further, we evaluated etoposide under steady-state and bolus dose conditions. In microdialysis infusion studies, etoposide 15 mg/kg/hr was administered to 12 rats. Rats received sodium cyanide (1 or 100 mM), trifluoperazine (30 mM) or cyclosporine (4.14 mM)via microdialysis probe at 3.5 hr after etoposide infusion initiation. High-dose sodium cyanide (100 mM) increased the etoposide BBR,corr from 0.09 ± 0.03 to 0.85 ± 0.35. Similarly, trifluoperazine significantly increased the BBR,corr (0.05 ± 0.02 vs. 1.30 ± 0.43), whereas cyclosporine had no effect. In bolus studies, etoposide (10–12 mg/kg) was given alone or concomitant to cyclosporine (5 mg/kg) or tamoxifen (13.5 mg/kg). Control etoposide total systemic clearance (ml/min/kg) was 29.3 ± 13.0 vs. 16.0 ± 1.9 and 22.6 ± 5.3 for cyclosporine and tamoxifen treatments, respectively. Etoposide nonrenal clearance (ml/min/kg) values for cyclosporine (12.0 ± 1.6) and tamoxifen (18.1 ± 3.6) treatments was also decreased from controls (23.5 ± 10.5). Etoposide renal clearance (ml/min/kg) values (5.7 ± 2.5) were not significantly different from cyclosporine (4.0 ± 0.7) or tamoxifen (4.6 ± 1.7) treatments, respectively. In this study, the ability of sodium cyanide and trifluoperazine to alter etoposide BBR,corr, demonstrated that etoposide distribution into brain is partly controlled by an active transport process. Similarly, the results indicate cyclosporine inhibits etoposide transport at the canalicular membrane and/or etoposide P-450 metabolism.

Footnotes

  • Send reprint requests to: Dr. Patrick J. McNamara, Division of Pharmacology and Experimental Therapeutics, College of Pharmacy, 433 College of Pharmacy Building, University of Kentucky, Lexington, KY 40536-0082. E-mail: pmcnamar{at}pop.uky.edu

  • ↵1 This work was supported, in part by the University of Kentucky Dissertation Year Fellowship (D.E.B.) and a University of Kentucky Medical Center Research Grant (P.J.M.).

  • ↵2 Present address: Quintiles, Inc., P.O. Box 13979, Research Triangle Park, NC 27709.

  • ↵3 Correspondence to Dr. Patrick J. McNamara, Division of Pharmacology and Experimental Therapeutics, College of Pharmacy, 433 College of Pharmacy Building, University of Kentucky, Lexington, KY 40536-0082. E-mail: pmcnamar{at}pop.uky.edu

  • Abbreviations:
    BBB
    blood-brain barrier
    CNS
    central nervous system
    • Received May 13, 1997.
    • Accepted July 23, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 287, Issue 3
1 Dec 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of P-glycoprotein Modulators on Etoposide Elimination and Central Nervous System Distribution
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Effects of P-glycoprotein Modulators on Etoposide Elimination and Central Nervous System Distribution

David E. Burgio, Michael P. Gosl and and Patrick J. McNamara
Journal of Pharmacology and Experimental Therapeutics December 1, 1998, 287 (3) 911-917;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Effects of P-glycoprotein Modulators on Etoposide Elimination and Central Nervous System Distribution

David E. Burgio, Michael P. Gosl and and Patrick J. McNamara
Journal of Pharmacology and Experimental Therapeutics December 1, 1998, 287 (3) 911-917;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
  • Use-Dependent ‘Agonist’ Effect of Azimilide on the HERG Channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics